Medical Information for AstraZeneca’s COVID-19 vaccine

For all Medical Information enquiries, about the AstraZeneca COVID-19 vaccine and to view the Information for UK Vaccine Recipients and Information for Healthcare Professionals please click here. 

If you are concerned about a side-effect, it can be reported directly via the Coronavirus Yellow Card reporting site https://coronavirus-yellowcard.mhra.gov.uk/, or search for MHRA Yellow Card in the Google Play or Apple App Store and include the vaccine brand and batch/lot number if available.

AstraZeneca in the UK

Bringing science to patients, creating value for Britain

UK Footprint

6,500 employees at 5 sites across the UK (as of May 2019)

9% of total pharmaceutical sector employment with a further 39,000 UK jobs supported including Research and Development, Manufacturing, Supply, Sales and Marketing

Patients

At the centre of what we do

Our purpose is to push the boundaries of science to deliver lifechanging medicines for patients. We partner with the scientific community to discover and develop these innovative treatments. We work with the NHS in areas such as patient pathway re-design, data, precision medicine and genomics. We are dedicated to collaborating with the NHS to make sure patients have access to the cutting-edge treatments they need. By using precision medicine in ~90% of our clinical pipeline, we aim to tailor new and existing treatments to the needs of individual patients through diagnostic tests.

Investment

In the future of UK science

We are investing over £500m in our future global HQ and strategic R&D centre in Cambridge. We have also invested £220m in new manufacturing, warehousing and infrastructure improvements at our Macclesfield campus between 2015-18, representing a spend of over £1m per week. This is the largest medicines manufacturing site in the UK.

VVPM ID: GB-26072 Date of Prep: December 2020